Albert Bourla, chairman and chief executive officer of the pharmaceutical company Pfizer. speaks in the Oval Office of the White House, Tuesday, Sept. 30, 2025, in Washington, as from left, Secretary ...

Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with the Trump administration, President Donald Trump said Tuesday.The announcement, ...

WASHINGTON (AP) — Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with the Trump administration, President Donald Trump said Tuesday.

President Donald Trump and the pharmaceutical giant Pfizer announced an agreement Tuesday to lower medication costs for Medicaid patients, advancing Trump’s “Most Favored Nation” pricing effort to ...

WASHINGTON -- Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals ...

President Donald Trump on Tuesday announced measures aimed at lowering the cost of prescription drugs in the United States, including an agreement with pharmaceutical giant Pfizer and the creation of ...

ADVANCING MOST-FAVORED-NATION PRICING: Today, President Donald J. Trump announced the first agreement with a major pharmaceutical company, Pfizer, to bring American drug prices in line with the lowest ...

Naturally, there's an AI component, courtesy of Alexa+. Don't miss out on our latest stories. Add PCMag as a preferred source on Google. Amazon announced a larger version of its work-focused Kindle ...

Zurich, Sept 29 (Reuters) - The Swiss National Bank is lowering the threshold factor for the interest it pays commercial banks on overnight deposits, a move designed to stimulate interbank lending and ...

Vaccines don’t just protect us from infectious diseases or lessen their effects. Some are also associated with a reduced risk for dementia, research shows. “They’ll protect against these really ...

A subcutaneously injected version of Merck cancer immunotherapy Keytruda is now FDA approved, a regulatory decision that gives patients a less burdensome dosing option and provides the pharmaceutical ...